alexa
Reach Us +44-7480-724769
Processing and Characterization of Silicon Nitride Bioceramics | OMICS International
ISSN:2090-5025
Bioceramics Development and Applications
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business

Processing and Characterization of Silicon Nitride Bioceramics

Bryan J. McEntire1*, Ramaswamy Lakshminarayanan2, Prabhakar Thirugnanasambandam3, Jacob Seitz-Sampson1, Ryan Bock1 and David O’Brien1

1Amedica Corporation, 1885 West 2100 South, Salt Lake City, UT 84119

2Corning, Inc., SP-FR-04, Corning, NY 14831

3Prismatik Dentalcraft, Inc., 2181 Dupont Dr., Irvine, CA 92612

Corresponding Author:
Bryan J McEntire
Chief Technology Officer, Amedica Corporation
1885 West 2100 South, Salt Lake City, UT 84119, USA
Tel: 8018393504
E-mail: [email protected]

Received date: April 25, 2016; Accepted date: May 23, 2016; Published date: May 30, 2016

Citation: McEntire, BJ et al. (2016) Processing and Characterization of Silicon Nitride Bioceramics. Bioceram Dev Appl 6:093. doi:10.4172/2090-5025.1000093

Copyright: © 2016 McEntire BJ, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Bioceramics Development and Applications

Abstract

As a relatively new biomaterial, silicon nitride (Si3N4) is currently used as an arthrodesis device in the cervical and thoracolumbar spine, and it is under consideration as a bearing material in total joint arthroplasty. In this paper, the development and validation of the manufacturing processes used in the production of Si3N4 biomedical implants are presented and discussed. Manufacturing was conducted in a facility specifically dedicated for this purpose using processes designed to yield net shape intervertebral spinal spacers by conventional dry-pressing, CNC machining of components in the green state, sintering, and hot isostatic pressing. These manufacturing methods were industrialized using Taguchi fractional factorial experimental designs, followed by implementation of statistical process controls. The roles of various processing parameters including raw materials, pressing, and firing conditions (i.e., time, temperature, and pressure) are elucidated. For these devices, it was demonstrated that acceptable physical, mechanical, and dimensional properties were consistently obtained from carefully designed and statistically controlled processes.

Keywords

Bioceramic; Process validation; Silicon nitride; Taguchi methods

Introduction

Silicon nitride (Si3N4) is a relatively new man-made material. Synthesized in 1859, it was first manufactured into useful refractory shapes in the 1950s-60s, but was not extensively developed as an engineered ceramic until the 1980s [1-4]. Since then, it has garnered considerable attention because of its unique combination of excellent room- and high-temperature mechanical strength, toughness, oxidation, and thermal shock resistance [1,5-15]. Si3N4 is currently used in demanding mechanical applications involving high loads, wear, and corrosion [16]. However, until recently, it was not widely considered appropriate for medical devices. Early researchers erroneously assumed that Si3N4 was not biocompatible in spite of a lack of adverse biologic reactions during long-term in vivo exposure [17-20]. Also, Si3N4 was considered to be an exotic expensive raw material requiring difficult fabrication steps. Conversely, oxide-based ceramics including alumina (Al2O3), zirconia (ZrO2), and zirconia-toughenedalumina (ZTA), were presumed to be less expensive than Si3N4. Although they were developed earlier and are now extensively used in total joint arthroplasty, processing of medical devices from oxide ceramics utilizes similar manufacturing equipment and process steps as Si3N4 and their respective raw material costs do not differ substantially [21-23]. Finally, it was believed that oxide ceramics (ZrO2 and ZTA in particular) provided improved performance over their non-oxide counterparts. However, in terms of strength and toughness, Si3N4 has comparable properties to medical-grade ZrO2 or ZTA, and it is ~2-3 times superior to medical-grade Al2O3 [24]. In addition to high strength and fracture toughness, Si3N4 has other unique properties that make it attractive for demanding orthopaedic applications including inherent phase stability, low wear, scratch resistance, hydrophilicity, improved radiographic imaging, and bacteriostasis [25]. It has been cleared by the US FDA and EU regulatory agencies for implantation as intervertebral spacers for stabilization of the cervical and thoracolumbar spine. It is also being developed for reconstructive applications (i.e., hip and knee arthroplasty) but has yet to receive regulatory clearance for these purposes. A photograph of current and future implantable medical devices made from Si3N4 is shown in (Figure 1). Manufacturing of these devices has been performed in a dedicated production facility specifically engineered for this purpose. In accordance with current good manufacturing practice (cGMP) regulatory guidelines, both the facility and the fabrication processes were subjected to rigorous validations [26]. Presented within this paper are summarized results of these validation studies for Si3N4 biomedical implants.

bioceramics-development-applications-implants-produced

Figure 1: Representative spinal and reconstructive implants produced from biomedical Si3N4. (Courtesy: Amedica Corporation.)

Materials and Methods

Raw materials

The overall silicon nitride composition was fixed (i.e., 6 wt.% Y2O3, 4 wt.% Al2O3, 90 wt.% Si3N4), but it is similar to commonly developed and currently used silicon nitrides in industrial applications [27-29]. Two sources of silicon nitride raw powder were examined within the validation study: Ube SN-E10 (Ube Industries, Tokyo, Japan) and Starck M11 HP (H. C. Starck, Goslar, Germany). Their respective material specifications are provided in (Table 1). Note that the properties of these two silicon nitrides are quite similar, but their synthesis methods differ considerably. Ube SN-E10 is prepared from high purity silicon diamide and ammonia, whereas Starck M-11 HP is prepared by nitriding silicon metal. The other two major inorganic raw materials were Y2O3 (Grade C, H. C. Starck, Goslar, Germany) and Al2O3 (Baikowski XRC-UFX-MAR, Malakoff, TX USA).

Properties SN E10 M11 HP
N (wt.%) >38.0 >38.5
O (wt.%) <2.0 <1.5
C (wt.%) <0.2 <0.2
Cl (ppm) <100 N/A
Fe (ppm) <100 <10
Ca (ppm) <50 <10
Al (ppm) <50 <50
Co (ppm) N/A <50
Cu (ppm) N/A <50
ß/(α+ß) (wt.%) <5 <10
Specific Surface Area (m2/gm) 12.2 15.7
Particle Size (µm)    
D90 1.2 1.77
D50 0.52 1.16
D10 0.28 0.67

Table 1: Physicochemical properties of Si3N4 raw materials.

Manufacturing processes

A flow diagram of the Si3N4 manufacturing operations for spinal fusion devices is shown in (Figure 2). Batching involved accurately weighing appropriate amounts of each raw material along with deionized water, dispersants, binders. These constituents were charged into attrition mills (Q2 and Q6 Attritors, Union Process, Akron, OH USA) equipped with high purity (99.95%) Si3N4 milling media [30]. Following milling, spray drying was performed using standard industrial dryers (Mobile Minor and SD-6.3, GEA Niro, Søborg, Denmark) to convert the liquid slurry to a dry powder [31]. After spray drying, classification of the spray dried powder was performed by passing the material through vibratory screen separators (Sweco ZS24, Florence, KY USA). The classified powder was then blended with a press lubricant in a twin shell V-blender (Laboratory Model, Patterson- Kelly, East Stroudsburg, PA USA). Dry-pressing of the conditioned spray dried powder was the next process step [32,33]. Uniaxial and isostatic equipment (TPA-30, Dorst America, Bethlehem, PA, USA, and CP-083, Avure Technologies, Columbus, OH, USA, respectively) were used for this purpose at pressures ranging from ~100 MPa to ~300 MPa. Pressure was adjusted for each powder lot to obtain a targeted green density and linear shrinkage. Typically, green densities in excess of 50% were generally required to effectively achieve densification during firing. Green machining of the pressed blanks was subsequently performed using programmed CNC vertical machining or turning centers (OM1, VF2, and OL1, Haas Automation, Oxnard, CA, USA) [34]. Laser etching and engraving of the machined components were performed next using high-powered Nd-YAG equipment (FOBA G5 Laser Marker, Alltec GmbH, Selmsdorf, Germany). These operations provide the green ceramic with a rough surface to ultimately aid in osseointegration of the spinal spacer, and to mark each component with lot and part numbers for regulatory traceability. Organic additives were decomposed and removed from the ceramic during a thermal treatment in batch kilns. This operation was performed either in air or in N2 (ModelCESVN06, Thermal Tek, Concord, North Carolina, USA, or Model 121224, Centorr Vacuum Industries, Nashua, NH, USA, respectively). For air-firing, temperatures did not exceed about 750°C to prevent reactive decomposition of the ceramic [35]. Decomposition is obviously suppressed when firing in nitrogen. In either case, organic compounds were decomposed and removed at temperatures between about 450°C to 600°C for time periods of about 2 hours. Subsequent to binder removal, parts were subjected to higher temperature bisque firing in nitrogen at temperatures up to 1200°C for 1 to 2 hours. Presintering of the Si3N4 was the next firing step. All Si3N4 raw materials contain a certain amount of oxygen as a native impurity, generally less than about 2%, in the form of silicon-dioxide (SiO2). During high temperature firing, some of this oxygen is converted to siliconmonoxide (SiO) gas. While researchers have determined that oxygen is necessary to obtain appropriate densification and high strength, too much oxygen can degrade properties [36]. Removal of excess SiO2 during pre-sintering decreases the amount of the intergranular glass phase, which has a resultant beneficial effect on mechanical properties [37]. In an oxygen depleted environment or in the presence of carbon, silicon-monoxide gas, SiO (g), is generated in accordance with the following series of reactions [38-43].

bioceramics-development-applications-process-flow

Figure 2: Manufacturing process flow diagram for production of biomedical intervertebral spinal spacers from Si3N4.

2Si3N4 (s) + 3O2 (g) → 6SiO (g) + 4N2 (g)      (1)

This reaction (i.e., Equation 1) occurs under reducing conditions when residual oxygen is present.

This reaction (i.e., Equation 1) occurs under reducing conditions when residual oxygen is present.

2Si3N4 (s) + 3O2 (g) → 6SiO (g) + 4N2 (g)

Si3N4 (s) +3SiO2 (s) → 6SiO (g) + 2N2 (g)      (2)

The foregoing reactions (i.e., Equation 2) occur under reducing conditions when SiO2 is present; and the next series of reactions (i.e., Equation 3) are possible under reducing conditions when carbon is present.

2SiO2 (s) → 2SiO (g) + O2 (g)

2C (s) + O2 (g) → 2CO (g)

SiO2 (s) + C (s) → SiO (g) + CO (g)

CO (g) + SiO (g) → SiC (s) + O2 (g)

SiO2 (s) + C (s) → SiC (s) + O2 (g)

2Si3N4 (s) + 3O2 (g) → 6SiO (g) + 4N2 (g)

2Si3N4 (s) + 3C (s) + 3SiO2 (s) → 3SiC (s) + 6SiO (g) + 4N2 (g)     (3)

Pre-sintering was generally conducted at temperatures between 1400°C and 1600°C for up to 2 hours. Sintering was the next, and perhaps the most important firing step. Densification and the irreversible α →ß phase transformation simultaneously occurred during this heat-treatment cycle [44]. The microstructure of the material evolved from equiaxed primary α-phase particles and ~50% open porosity to interlocking needle-like ß-phase grains and <5% closed porosity [45,46]. Components were fired in nitrogen in a batch furnace with a slight N2 overpressure (+ 13.7 kPa), or in a continuous furnace at ambient pressure under flowing N2 (Centorr Vacuum Industries, Nashua, NH, USA), or in a hot-isostatic press (HIP) (QIH-21 Avure Technologies Columbus, OH) at pressures ranging from about 0.7 MPa, to 10 MPa. After sintering components to closed porosity, hot-isostatic pressing (HIPing) was performed to remove residual pores from the fired bodies and to coarsen the ß-Si3N4 grains within the microstructure. Coarsening improves their interlocking behavior which translates to increased fracture toughness. The sintering and HIPing conditions explored within this study included temperatures of between 1650°C to 1800°C, times of up to 3 hours, and pressures between ~100 MPa and ~200 MPa.

At the end of the process, components were inspected for density by an Archimedes method (i.e., ASTM C-373) using a typical analytical balance (XS205, Metler Toledo, Columbus, OH, USA). They were then proof-tested in specially designed fixtures using a compression testing machine (5567, Instron, Norwood, MA, USA). Proof-testing involved axially loading each part to a pre-determined limit based on finite element analyses or other analytical or empirical methods. Proof-testing has been effectively used to eliminate defective components in other biomedical ceramics [47]. Following prooftesting, a detailed microscopic visual inspection was conducted, (Stereomicroscopes, Zeiss Inc., Ontario, CA, USA), which in turn was followed by dimensional inspection using either a semi-automated visual measuring system (Smartscope MVP 200, OGP, Rochester, NY) or a coordinate measuring machine (CMM, Contura, Zeiss, Brighton, MI, USA). Mechanical testing was performed using standard test bars (3 mm x 4 mm x 45 mm) in accordance with ASTM C-1161 and ASTM E-399 for 3-pt. flexural and fracture toughness measurements, respectively. Scanning electron microscopy (SEM) was carried out using a field emission gun scanning electron microscope (FEG-SEM) (Quanta, FEI, Hillsboro, OR, USA). All samples were sputter-coated (108 auto, Cressington, Watford, UK) with a thin (~20 to 30Å) layer of gold. Samples were imaged using an accelerating voltage of 10 kV at working distances of 7-10 mm and spot sizes of 4-5 mm. Analysis of variance was utilized to determine statistical significance for all measureable physical and mechanical properties, using sample sizes of n ≥ 5 for density measurements and n ≥ 20 for strength determination.

Process validation methodology

While effective process validations address every vital step of the manufacturing process, from a practical standpoint, the effort is typically limited to the most critical process parameters (CPPs, i.e., those having the greatest impact on the safety or efficacy of the finished medical device). An assessment of the Si3N4 manufacturing process indicated that there were 14 major steps, with ~45 potential CPPs, and +80 possible alternative conditions. Clearly, this was too many to be easily and systematically evaluated within the validation study. Consequently, a process failure modes and effects analysis (PFMEA) was performed to down select and rank only those CPPs considered to be most important [48]. Its completion resulted in the following prioritized production operations and parameters requiring detailed investigation:

(1) Raw materials – Si3N4

(2) Pressing – pressure

(3) Pre-sintering – temperature and time

(4) Sintering – temperature and time

(5) HIPing – temperature, time, and pressure.

The remaining parameters were pre-determined and held constant based on prior industrial experience, peer reviewed literature, or from small Taguchi fractional factorial screening experiments [49]. Larger Taguchi experiments were then designed and conducted to evaluate and correlate interactions between the selected CPPs [50]. Taguchi experimental designs and methodologies are particularly efficient in determining important parameters, and in robustly controlling manufacturing processes [51,52].

Results and Discussion

Process validation studies

Following several screening experiments, a number of larger surface response studies were designed and conducted. These were directed at exploring interactive effects between the identified CPPs. Two of the studies are presented here as examples:

(1) An L8 study correlating raw material, pre-sintering, and sintering conditions.

(2) An L18 study testing the effects of binder composition, HIPing, and sintering conditions.

The experimental designs for these two studies and results are shown in Tables 2a and 3a, respectively, with their corresponding ANOVAs presented in Tables 2b ~ 2c and 3b ~ 3c, respectively. For each experiment, standard flexural test bars were prepared and characterized for density and flexural strength. Analyses of Variance (ANOVA) were then conducted to determine the significance of the results using F-statistics at p values ≤ 0.05.

Raw
Material
Pre-Sinter Sintering
Temp.
Sintering Time Sintered
Density (g/cc)
HIPed
Density (g/cc)
Flexural Strength (MPa)
Starck M11-HP On Low Short 3.086 ± 0.008 3.202 ± 0.007 611 ± 52
High Long 3.202 ± 0.009 3.256 ± 0.005 748 ± 143
Off Low Long 3.123 ± 0.005 3.213 ± 0.012 623 ± 108
High Short 3.069 ± 0.012 3.201 ± 0.010 639 ± 88
Ube SN-E10 On Low Short 3.171 ± 0.014 3.251 ± 0.002 1,050 ± 147
High Long 3.225 ±0.013 3.259 ± 0.006 994 ± 148
Off Low Long 3.187 ± 0.007 3.251 ± 0.004 1,090 ± 150
High Short 3.168 ± 0.011 3.243 ± 0.003 1,076 ± 149

Table 2a: Taguchi L8 experiment examining the effects of raw material, pre-sinter condition, sintering temperature and time on physical and mechanical properties of biomedical Si3N4.

For the L8 design, the results provide an interesting comparison between the two Si3N4 raw materials. There appeared to be substantial benefit from using Ube SN-E10 over Starck M11-HP in the chosen validation range. While the best HIPed densities of the two materials were essentially equivalent, strength results were ~240 MPa higher when using Ube SN-E10. The best average strength obtained using Starck M11-HP was ~750 MPa, whereas the best data from Ube SNE10 was ~1,075 MPa. Note that Ube SN-E10 has a much broader processing window, particularly with respect to sintering temperature. The range of HIPed densities for SN-E10 was between 3.243 and 3.259 g/cc, (range of 0.016), whereas Starck M11-HP provided data between 3.201 and 3.256 g/cc (range of 0.055). Theoretical density for these compositions was calculated to be 3.271 g/cc based on the rule of mixtures. Consequently, observed data ranged from 97.86% to 99.54% of this theoretical value. Differences between maximum and minimum HIPed densities for the Ube SN-E10 and Starck M-11 materials were less than 1.74%. The corresponding average strengths for Ube SN-E10 ranged from 994 MPa to 1,090 MPa (range 96 MPa) whereas Starck M-11HP ranged from 611 MPa to 748 MPa (range of 137 MPa; (Table 2a). For sintered density, all four experimental factors were statistically significant within the L8 ANOVA, but the greatest contribution came from the raw material source, followed by sintering time, then pre-sinter condition, and finally sintering temperature (cf., Table 2b). The observation that sintering time is a more important variable than temperature is desirable from a processing viewpoint. Time can be precisely determined and controlled, whereas temperature fluctuations of up to ± 40°C may occur, but will likely still produce a quality product. The L8 ANOVA for flexural strength indicated that the only governing factor was raw material (cf. Table 2c). All other variables were insignificant when compared with experimental error. SEM photographs of contrasting microstructures for the two raw materials processed under identical conditions are shown in Figures 3a and 3b. While quantitative analyses of grain size and distribution were not performed, differences in mechanical properties between the Ube SN-E10 and Starck M-11 compositions were self-evident from their respective microstructures (cf., Figures 3a and 3b). The estimated average grain size for the Starck M-11 composition was approximately 2x that of the comparable Ube SN-E10 composition, which is the principal reason for its lower strength [11]. It is believed that the agglomerated nature of the Starck M-11 powder was the reason for the larger observed grain size (cf., Table 1). Even though it had an intrinsic surface area that was comparable to the SN-E10 powder (cf., Table 1), the M11 raw material required extensive milling to reduce it to its primary particles. Under comparable milling conditions, the Ube powder proved to be superior. However, it has also been shown that powders possessing higher starting ß-phase contents can also cause exaggerated grain growth, which results in lower strengths [53]. Based on the output of this L8 study, preferred conditions for raw material, pre-sintering, sintering time, and temperature included use of Ube SN-E10 powder, incorporation of a pre-sintering step, and sintering at a lower temperature for a shorter time. Given the selection of these conditions, expected physical and mechanical properties for biomedical Si3N4 were: average density ≥ 3.25 g/cc (i.e., >99.4%); and average flexural strength above 1,000 MPa.

Source SS df MS F P % Contribution
Raw Mat'l 0.2557 1 0.25569 2400.629 0 40.49%
Sinter Temp 0.0328 1 0.03283 308.27 0 5.20%
Sinter Time 0.2056 1 0.20565 1930.776 0 32.57%
Pre-Sinter 0.0664 1 0.0664 623.437 0 10.52%
AB 0.0029 1 0.00285 26.765 0 0.45%
AC 0.0336 1 0.03362 315.678 0 5.32%
AD 0.0114 1 0.01144 107.417 0 1.81%
Error 0.023 216 0.00011     3.64%
Total 0.6315 223        

Table 2b: Taguchi L8 ANOVA for sintered density.

Source SS df MS F P % Contribution
Raw Mat'l 8833941 1 8833941 647.025 0 72.00%
Temp 23206.7 1 23206.7 1.7 0.194 0.19%
Time 23074.2 1 23074.2 1.69 0.195 0.19%
Pre-Sinter 2569.8 1 2569.8 0.188 0.665 0.02%
AB 174298.5 1 174298.5 12.766 0 1.42%
AC 90398.6 1 90398.6 6.621 0.011 0.74%
AD 172624.5 1 172624.5 12.644 0 1.41%
Error 2949084 216 13653.17     24.04%
Total 12269198 223        

Table 2c: Taguchi L8 ANOVA for flexural strength.

bioceramics-development-applications-raw-materials

Figure 3: Representative microstructures of dense Si3N4 prepared using different raw materials under the following conditions: Pre-sinter – off; Sintering temperature – low; Sintering time – long; (a) Ube SN-E10 and (b) Starck M11-HP.

For the larger Taguchi L18 experimental array, the Ube SN-E10 raw material was exclusively employed. The experiment examined both the nominal and a range of conditions (high and low) for binder composition, pre-sintering, sintering, and HIPing. Note particularly that time was not examined as a part of this study based on the prior work. It was held constant for these tests so that effects of the remaining parameters could be readily examined. The results of this study are presented in Table 3a. ANOVA results are provided in Tables 3b and 3c. There are several interesting observations from these data. First, all processing conditions gave excellent densities, both sintered and HIPed. The average sintered and HIPed densities for all conditions were 3.237 g/cc (99.29%) and 3.258 g/cc (99.94%), respectively. Second, although there are observable differences in flexural strength, preferred conditions provided values comparable to those obtained in earlier studies. Note particularly that lower firing temperatures gave the best values (i.e., an average of 950 MPa). This was likely the result of a reduction in average grain size associated with the lower temperature. Weibull modulus and characteristic Weibull strength were also compiled from the individual data (not shown). Preferred conditions yielded an average modulus value of >10.0 and characteristic strength in excess of 1,000 MPa. Several ANOVAs were conducted using the flexural strength data of Table 3a, including an L18 analysis of all conditions (i.e., Table 3b) and a separate L6 analysis which excluded an examination of pre-sintering conditions (i.e., Table 3c). These analyses suggested that three of the experimental factors were significant (p ≤ 0.05):

Organics Pre-Sinter Sinter Temp. HIP Temp. HIP Pressure Sinter Density (g/cc) HIP Density (g/cc) Flexural Strength (MPa)
No. 1 High in N2 Low Low High 3.234 ± 0.003 3.262 ± 0.006 935 ± 223
  Middle Middle Middle 3.237 ± 0.002 3.260 ± 0.005 964 ± 203
  High High Low 3.238 ± 0.005 3.262 ± 0.008 796 ± 96
  Low in Vacuum Middle High High 3.239 ± 0.001 3.259 ± 0.013 859 ± 107
  High Low Middle 3.241 ± 0.001 3.262 ± 0.003 835 ± 136
  Low Middle Low 3.234 ± 0.002 3.260 ± 0.01 958 ± 138
  None High Middle High 3.236 ± 0.003 3.262 ± 0.008 789 ± 202
  Low High Middle 3.229 ± 0.003 3.262 ± 0.005 849 ± 193
  Middle Low Low 3.236 ± 0.002 3.259 ± 0.004 937 ± 76
No. 2 High in N2 Low Low High 3.234 ± 0.007 3.245 ± 0.003 948 ± 105
  Middle Middle Middle 3.238 ± 0.005 3.257 ± 0.010 930 ± 147
  High High Low 3.245 ± 0.001 3.250 ± 0.007 825 ± 80
  Low in Vacuum Middle High High 3.240 ± 0.002 3.253 ± 0.010 835 ± 90
  High Low Middle 3.243 ± 0.002 3.265 ± 0.004 857 ± 87
  Low Middle Low 3.233 ± 0.004 3.268 ± 0.005 983 ± 130
  None High Middle High 3.239 ± 0.011 3.253 ± 0.011 779 ± 117
  Low High Middle 3.225 ± 0.004 3.247 ± 0.008 872 ± 74
  Middle Low Low 3.236 ± 0.021 3.260 ± 0.006 924 ± 96

Table 3a: Taguchi L18 experiment examining the effects of binder composition, pre-sintering, sintering, and hot-isostatic pressing conditions on physical and mechanical properties of biomedical Si3N4.

Source SS df MS F P %  Contribution
Powder Composition 2866 1 2866 0.156 0.693 0.03%
Pre-Sinter Condition 270512 2 135256 7.364 0.001 2.98%
Sinter Temperature 1145100 2 572550.1 31.172 0 12.61%
HIP Temperature 582367.1 2 291183.5 15.853 0 6.41%
HIP Pressure 29418.3 2 14709.2 0.801 0.45 0.32%
BC 0 4 0 0 1 0.00%
BCD 0 8 0 0 1 0.00%
BCE 0 8 0 0 1 0.00%
BD 0 4 0 0 1 0.00%
BDE 0 8 0 0 1 0.00%
BE 0 4 0 0 1 0.00%
CD 0 4 0 0 1 0.00%
CDE 0 8 0 0 1 0.00%
CE 0 4 0 0 1 0.00%
DE 0 4 0 0 1 0.00%
Error 7053180 384 18367.66     77.65%
Total 9083443 449        

Table 3b: L18 ANOVA for powder composition, pre-sinter, sinter and hip processes-verification experiment.

Source SS df MS F P % Contribution
Powder Composition 87.6 1 87.6 0.005 0.945 0.00%
Sinter Temperature 921158.7 2 460579.3 24.908 0 26.52%
HIP Temperature 0 2 0 0 1 0.00%
HIP Pressure 0 2 0 0 1 0.00%
BC 0 4 0 0 1 0.00%
Error 2551791 138 18491.24     73.47%
Total 3473037 149        

Table 3c: L6 ANOVA for powder composition, pre-sinter, sinter, and hip processes – verification experiment.

(1) Sintering temperature;

(2) HIP temperature; and

(3) Pre-sinter condition.

There were no observed interactive effects between any of the variables. It is especially important to note that HIP pressure (within the range studied) and binder composition had essentially no effect. The ANOVA of Table 3b for flexural strength suggests sintering temperature had the most effect (outside of experimental error). This is not surprising, given that most of the microstructural development occurs during the early stages of densification. The subsequent hotisostatic press operation only eliminates closed porosity and uniformly coarsens the microstructure.

Since the observed results of Table 3a suggested that an intermediate pre-sinter condition in N2 was preferred, the L6 ANOVA was completed to determine which of the remaining factors were important (i.e., Table 3c). This analysis indicated that sintering temperature was the most important factor (p ≤ 0.05). Binder composition, HIP temperature, and pressure played no role, and there were no other interactive effects.

The results of these two Taguchi studies confirmed observations conducted in the earlier validation tests. Correlation and trend line analyses were subsequently performed using data from all of the experimental conditions [52]. The results indicated that a fairly broad range in sintering temperatures provided adequate flexural strength. As expected, the highest predicted strengths (~1,090 MPa) occurred for the lowest sintering temperature.

As the sintering temperature increased, strength decreased regardless of other process factors. At a constant and relatively low sintering temperature, successively higher HIP temperatures also resulted in decreased strengths. Both are likely due to microstructural coarsening. The data suggest that the lowest sintering and HIP temperatures are preferred, but also indicate that the acceptable range was fairly broad (i.e., ± 40°C). There were very little observed differences between various HIP pressures. The data suggested that a lower HIP pressure is preferred, but the acceptable range is inclusive of all conditions studied within the experiments.

Process verification

Final selection of process parameters and ranges were determined pursuant to completion of the validation experiments described in the previous section. Multiple production powder lots were subsequently produced. From the powder lots, both test-bars and actual production components were prepared and evaluated to verify the efficacy of the selected conditions. Critical outcomes included the attainment of required dimensions and tolerances on actual components, and achievement of minimum physical and mechanical properties on co-processed test-bars. Powder compaction was analyzed for each production powder lot, including assessments for green density and linear shrinkage at various compaction pressures. Tight controls over press density were necessary to meet final dimensional tolerances. However, minor differences between various powder lots were compensated by slight changes in compaction pressure. Results for four production lots are presented in Figures 4a and 4b, respectively. These density and shrinkage curves provide important engineering information for predicting as-fired part dimensions. Empirical relationships correlating green density and shrinkage have been extensively investigated and are highly predictable [32,54]. Both linear shrinkage and green density can be adequately modeled using logarithmic functions of compaction pressure. Note that excellent correlation coefficients (>0.99) for these empirical equations were achieved. Using the engineering information of Figures 4a and 4b, specific press parameters and dimensions were chosen for green forming operations (i.e., pressing and green machining) of intervertebral spinal spacers. Statistical process controls (SPC) were implemented on pressed ware and green machined components [55-57]. Sequentially collected data on the weight and height of each part were used to calculate green densities and predict linear shrinkage. Tracking of linear shrinkage was used to monitor and adjust the pressing operation to ensure appropriate dimensional control over finished components. These SPC controls are shown in Figures 5a and 5b using X-bar R-charts and process capability analyses (i.e., Cp and Cpk), respectively. While these controls were used on every lot, only one component production work order comprising approximately 250 individual pieces is shown as a representative example in Figures 5a and 5b. When slight out of control conditions occurred (according to SPC rules) [58], this information was immediately available to the press operator in order to make minor adjustments to either part weight or height and bring the process back within control. The Cpk analysis demonstrated excellent overall process capability. Target shrinkage for this specific lot was 20.5% at a compaction pressure of ~207 MPa, with the range of acceptable shrinkage varying between 20.35% and 20.65%, yielding a Cpk value of greater than 1.79 (i.e, a sigma level of~5.4). Processes are said to be in good control if their Cpk value is greater than 1.33. All final component features were then machined or laser etched into the pressed blanks, leaving them with the precise amount of green stock to shrink to their final dimensions during the firing processes.

bioceramics-development-applications-shrinkage-behavior

Figure 4: Compaction and shrinkage behavior of four production powder lots used for biomedical Si3N4 intervertebral spinal spacers in (a) and (b), respectively.

bioceramics-development-applications-Statistical-process

Figure 5: Statistical process control charts and process capability indices for a typical production lot of intervertebral spinal spacers from a biomedical Si3N4 in (a) and (b), respectively.

While forming operations primarily defined dimensional features and tolerances, physical and mechanical properties were the product of powder composition and firing processes. Since the composition for this Si3N4 biomaterial was fixed, conditions selected for pre-sintering, sintering, and HIPing principally determined these characteristics, as demonstrated by the validation results given previously. Density, flexural strength, and fracture toughness data were compiled from co-processed test specimens from production powder lots. Provided in Figure 6 are density results compiled from 194 sequentially manufactured component batches comprised of 8 different powder lots. Component batches are subsets of production powder lots and are defined by their unique part numbers. They can range in quantity from as small as eight to several hundred pieces; whereas production powder lots can range from 150 to 300 kg. Density measurements were performed on samples from each component batch, with a lower specification limit set at ≥ 3.23 g/cc (98.75%). No component batches fell below this minimum, with the average being 3.254 g/cc for all 194 batches. Mechanical properties, including flexural strength and fracture toughness, were assessed for all powder lots. Figure 7 presents results from 26 different sequentially produced powder lots. Flexural strengths were acquired on all lots, while fracture toughness measurements were acquired only for the first ten lots, and sampled for selected lots thereafter. Average results for flexural strength and fracture toughness were 995 MPa and 10.6 MPaâm1/2, respectively, with the range of individual lots falling within one standard deviation of the overall mean. These results demonstrate reasonable repeatability and control for mechanical properties within the manufacturing process.

bioceramics-development-applications-batches-comprised

Figure 6: Mass density results from 194 sequential component batches comprised of eight different powder lots of a biomedical Si3N4.

bioceramics-development-applications-Flexural-strength

Figure 6: Flexural strength and fracture toughness evaluations for sequentially produced production Si3N4 powder lots.

Conclusion

A dedicated and vertically integrated factory established for the purpose of manufacturing intervertebral spinal spacers from a biomedical Si3N4 was subjected to process validation and verification in accordance with regulatory requirements. Efficient Taguchi fractional factorial designed experiments were utilized to assess and correlate critical process parameters to product properties. Results demonstrated that selection of raw materials, particularly the Si3N4 powder source, and firing conditions had the most effect on physical and mechanical properties, with binder composition and compaction pressure affecting dimensional characteristics. Using these experiments, process parameters were subsequently selected to provide acceptable and consistent results for multiple production powder lots and individual component batches. It was demonstrated that the adopted processes were capable of achieving tight statistical controls over dimensions (i.e., Cpk and sigma level of >1.79 and ~5.4, respectively), with average flexural strengths and fracture toughness values of 995 MPa and 10.6 MPaâm1/2, respectively. Manufacturing of biomedical Si3N4 ceramics has been conducted since 2008 using the processes and parameters described herein.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 12981
  • [From(publication date):
    June-2016 - Dec 14, 2019]
  • Breakdown by view type
  • HTML page views : 12635
  • PDF downloads : 346

Review summary

  1. Aaaliah
    Posted on Aug 04 2016 at 11:12 am
    The article discussed the various aspects that need to be considered to prepare clinical grade silicon nitride that may be used in surgical interventions including arthroplasty. The article is a significant contribution in the field of bioceramics and will help in the development and usage of highly improved and biocompatible materials for clinical usage.

Post your comment

captcha   Reload  Can't read the image? click here to refresh
Peer Reviewed Journals

Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals

Top